deCODE Biostructures Group
Business Identifier: NO Business Identifier is currently available for this company.
Public Profile:
Originally acquired by Medichem Research, IL (itself an SBIR firm), Emerald BioStructures offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. In March 2002, Medichem was acquired by the Icelandic firm deCODE genetics, Inc. Being foreign owned and outisde the size limits of SBIR, neither firm is now program eligible

 Synopsis: Awardee Business Condition
Year Founded IP Holdings
Employee Range VC funded?
Revenue Range Private/Public
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Automated Protein Crystal Growth in Lipidic Cubic Phase
Crystallization Tools for Structural Genomics
Anticancer Drug Design Targeting Human Topoisomerase I
High-Throughput Crystallization of Proteins
Anticancer Compounds Designed to Poison Topoisomerase I